Annovis Announces $3.4 Million Registered Direct Offering of Common Stock Priced At-the-Market under the NYSE Rules GlobeNewswire October 27, 2025 MALVERN, Pa., Oct. 27, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and […]

(NASDAQ:SNYR), WESTBROOK, Maine, Oct. 27, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced that its flagship brain-health supplement brand, FOCUSfactor(R), has been recognized as the #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026, according to the latest Pharmacy Times survey of pharmacists' over-the-counter (OTC) recommendations.

Rezolve Ai to Participate in Upcoming Investor Conferences Hosted by RBC Capital Markets and Roth Capital Partners GlobeNewswire October 27, 2025 NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a leader in AI-powered commerce solutions, announced that it will participate in two upcoming investor conferences. Daniel M. Wagner, Rezolve Ai's Founder

Washington, D.C., Oct. 27, 2025 (GLOBE NEWSWIRE) — A once-ignored corner of the American economy is roaring back to life. After years of dependence on Chinese supply chains, the Pentagon has launched a sweeping plan to rebuild domestic production of the metals that power jet engines, electric grids, and A.I. hardware. Public filings show more

(NASDAQ:AMRX), Brekiya(R) autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling Specialty Pharmacy BRIDGEWATER, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the U.S. commercial launch of Brekiya(R) (dihydroergotamine mesylate) injection, the first and only

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire October 27, 2025 Fort Lee, NJ, Oct. 27, 2025 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of

(NASDAQ:VTSI), CHANDLER, Ariz., Oct. 27, 2025 (GLOBE NEWSWIRE) — VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use-of-force and firearms training simulators, will hold a conference call on Monday, November 10, 2025 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the third quarter

Comfort Is the New Beautiful: EKOUAER x Bedsure Launch New Collection to Redefine Comfort as a Lifestyle GlobeNewswire October 27, 2025 NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) — Fresh off its 10th anniversary celebration, EKOUAER unveils a new milestone in collaboration with global home brand Bedsure, presenting a limited-edition collection built around the concept

(NASDAQ:APYX), CLEARWATER, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) — Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion(R) and the AYON Body Contouring System(TM), today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following

Creative Health Care Insight Announces Exclusive Partnership with Renowned Nursing Education Innovator Dr. Ellen Joswiak, Launching Revolutionary TSAM(R) Implementation Consulting Education Industry-First Partnership Will Launch the CHCI Exclusive Consulting Division and Nationwide Workshop Series Delivering the Evidence-Based Clinical Tiered Orientation Framework to Health Care Organizations GlobeNewswire October 27, 2025 Nashville, TN, Oct. 27, 2025 (GLOBE